Axel Polack

Axel Polack is a prominent figure in the biotechnology and venture capital sectors, serving as a Member of the Board ("Verwaltungsrat") at Virometix AG, a Swiss biotechnology company.12 Here are some key details about Axel Polack:

Professional Background

Venture Capital Experience: Axel Polack is a General Partner at JPIF (Joint Polish Investment Fund), a life-science-oriented early-stage venture capital fund.2 This role showcases his expertise in identifying and supporting promising biotech ventures.

Board Memberships: In addition to his position at Virometix AG, Polack serves on the supervisory boards of several companies:

• HealthUp Sp.zo.o
• Survivor Life Ltd2

Advisory Roles: He acts as a senior advisor to the Else Kröner-Fresenius-Stiftung (EKFS), a non-profit foundation dedicated to advancing medical research and medical-humanitarian projects.2

Academic and Medical Background

Axel Polack holds impressive academic credentials:

• Medical Doctorate from the University of Freiberg
• Second doctorate (Privatdozent) in Virology from the Ludwig-Maximilians Universität (LMU) Munich2

Career Path

Dr. Polack's career has evolved through three notable phases, encompassing achievements in:

1. Venture capital
2. Business management
3. Biomedical research2

Current Positions

• Founder and CSO at Neotes GmbH
• Managing director at Polack Holding GmbH
• Member of the Board at Virometix AG3

Axel Polack's diverse experience in venture capital, biotechnology, and medical research makes him a valuable asset to Virometix AG's board, contributing to the company's development of new generation vaccines and immunotherapeutic drugs.12